"Designing Growth Strategies is in our DNA"

Chronic Obstructive Pulmonary Disease Drugs Market Size, Share and Global Trend By Drug Class (Bronchodilators, Steroids, Combination drugs), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online pharmacy), and Geography Forecast till 2026

In February 2019, FDA approved the use of Yupelri inhalation solution manufactured by Mylan for patients suffering from chronic obstructive pulmonary disease. According t... Read More

Final report will be updated to address the impact of COVID-19 on this particular market

Region : Global | Published Date: Upcoming | Report ID: FBI101176 | Status : Upcoming

 

Request PDF Brochure

Refresh Button
Chronic Obstructive Pulmonary Disease Drugs Market Size, Share and Global Industry Trend Forecast till 2025
  • PDF
  • 2018
  • 2014-2018
  • Direct Purchase
  • 4850
    6850
    8850

Healthcare Clients

DUPONT
Abbott
baxter
lpsos
Logo_Merck_KGaA_2015
chong-kun-dang
DAEWOONG
Natus-Medical
SUANFARMA
Bio-Rad
Intuitive_Surgical_logo
novo-nordisk
Ge-Healthcare
Sedana-Cyan-Black-Tag


We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X